Vol 6, No 9 (May 15, 2018): Annals of Translational Medicine (Focus on “Translational approach to investigation of solid tumor malignancies”)

Review Article

Colorectal cancer genomics and designing rational trials
Sebastian Mondaca, Rona Yaeger
Annals of Translational Medicine
 2018;
6
(9)
:159
Emerging application of genomics-guided therapeutics in personalized lung cancer treatment
Aubhishek Zaman, Trever G. Bivona
Annals of Translational Medicine
 2018;
6
(9)
:160
Prostate cancer in the era of “Omic” medicine: recognizing the importance of DNA damage repair pathways
Zachary Kornberg, Jonathan Chou, Felix Y. Feng, Charles J. Ryan
Annals of Translational Medicine
 2018;
6
(9)
:161

Original Article

Optimization of a microfluidics-based next generation sequencing assay for clinical oncology diagnostics
Christine Henzler, Matthew Schomaker, Rendong Yang, Aaron P. Lambert, Rebecca LaRue, Robyn Kincaid, Kenneth Beckman, Teresa Kemmer, Jon Wilson, Sophia Yohe, Bharat Thyagarajan, Andrew C. Nelson
Annals of Translational Medicine
 2018;
6
(9)
:162

Original Article

Survival outcomes for advanced kidney cancer patients in the era of targeted therapies
Arpit Rao, Charles Wiggins, Richard C. Lauer
Annals of Translational Medicine
 2018;
6
(9)
:165

Perspective

Transforming research: engaging patient advocates at all stages of cancer research
AnneMarie Ciccarella, Alicia C. Staley, Aime T. Franco
Annals of Translational Medicine
 2018;
6
(9)
:167

Disclosure:

The focused issue “Translational approach to investigation of solid tumor malignancies” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding. Emil Lou served as the unpaid Guest Editor for the focused issue.